First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles - case report

Am J Reprod Immunol. 2010 Aug 1;64(2):93-6. doi: 10.1111/j.1600-0897.2010.00826.x. Epub 2010 Mar 17.

Abstract

Problem: Does addition of enoxaparin to sildenafil and etanercept immunotherapy improve IVF outcome?

Methods: Report of a striking case with 15 IVF failures.

Result: When enoxaparin was added, the 16th IVF cycle generated a healthy male baby.

Conclusions: Combination therapy that includes a heparin may allow successful IVF outcome and this issue merits further study.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Cytotoxicity, Immunologic / drug effects
  • Drug Therapy, Combination
  • Endometriosis / drug therapy
  • Endometriosis / immunology
  • Enoxaparin / therapeutic use*
  • Etanercept
  • Female
  • Fertilization in Vitro*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use
  • Immunotherapy / methods*
  • Killer Cells, Natural / drug effects
  • Live Birth
  • Middle Aged
  • Piperazines / therapeutic use*
  • Pregnancy
  • Pregnancy Complications
  • Purines / therapeutic use
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Sildenafil Citrate
  • Sulfones / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Enoxaparin
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Piperazines
  • Purines
  • Receptors, Tumor Necrosis Factor
  • Sulfones
  • Tumor Necrosis Factor-alpha
  • Sildenafil Citrate
  • Etanercept